These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 19232440

  • 1. Administration of a monomeric CCL2 variant to EAE mice inhibits inflammatory cell recruitment and protects from demyelination and axonal loss.
    Brini E, Ruffini F, Bergami A, Brambilla E, Dati G, Greco B, Cirillo R, Proudfoot AE, Comi G, Furlan R, Zaratin P, Martino G.
    J Neuroimmunol; 2009 Apr 30; 209(1-2):33-9. PubMed ID: 19232440
    [Abstract] [Full Text] [Related]

  • 2. Therapeutic effects of combined treatment with ribavirin and tiazofurin on experimental autoimmune encephalomyelitis development: clinical and histopathological evaluation.
    Stojkov D, Lavrnja I, Pekovic S, Dacic S, Bjelobaba I, Mostarica-Stojkovic M, Stosic-Grujicic S, Jovanovic S, Nedeljkovic N, Rakic L, Stojiljkovic M.
    J Neurol Sci; 2008 Apr 15; 267(1-2):76-85. PubMed ID: 17996253
    [Abstract] [Full Text] [Related]

  • 3. Endogenous leukemia inhibitory factor production limits autoimmune demyelination and oligodendrocyte loss.
    Butzkueven H, Emery B, Cipriani T, Marriott MP, Kilpatrick TJ.
    Glia; 2006 May 15; 53(7):696-703. PubMed ID: 16498619
    [Abstract] [Full Text] [Related]

  • 4. T cells contribute to lysophosphatidylcholine-induced macrophage activation and demyelination in the CNS.
    Ghasemlou N, Jeong SY, Lacroix S, David S.
    Glia; 2007 Feb 15; 55(3):294-302. PubMed ID: 17096403
    [Abstract] [Full Text] [Related]

  • 5. Astrocyte-associated axonal damage in pre-onset stages of experimental autoimmune encephalomyelitis.
    Wang D, Ayers MM, Catmull DV, Hazelwood LJ, Bernard CC, Orian JM.
    Glia; 2005 Aug 15; 51(3):235-40. PubMed ID: 15812814
    [Abstract] [Full Text] [Related]

  • 6. VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE.
    Roscoe WA, Welsh ME, Carter DE, Karlik SJ.
    J Neuroimmunol; 2009 Apr 30; 209(1-2):6-15. PubMed ID: 19233483
    [Abstract] [Full Text] [Related]

  • 7. Oral administration of 1,4-aryl-2-mercaptoimidazole inhibits T-cell proliferation and reduces clinical severity in the murine experimental autoimmune encephalomyelitis model.
    Jung EJ, Hur M, Kim YL, Lee GH, Kim J, Kim I, Lee M, Han HK, Kim MS, Hwang S, Kim S, Woo AM, Yoon Y, Park HJ, Won J.
    J Pharmacol Exp Ther; 2009 Dec 30; 331(3):1005-13. PubMed ID: 19741152
    [Abstract] [Full Text] [Related]

  • 8. Demyelination caused by the copper chelator cuprizone halts T cell mediated autoimmune neuroinflammation.
    Maña P, Fordham SA, Staykova MA, Correcha M, Silva D, Willenborg DO, Liñares D.
    J Neuroimmunol; 2009 May 29; 210(1-2):13-21. PubMed ID: 19344958
    [Abstract] [Full Text] [Related]

  • 9. FK506 and a nonimmunosuppressant derivative reduce axonal and myelin damage in experimental autoimmune encephalomyelitis: neuroimmunophilin ligand-mediated neuroprotection in a model of multiple sclerosis.
    Gold BG, Voda J, Yu X, McKeon G, Bourdette DN.
    J Neurosci Res; 2004 Aug 01; 77(3):367-77. PubMed ID: 15248293
    [Abstract] [Full Text] [Related]

  • 10. Andrographolide interferes with T cell activation and reduces experimental autoimmune encephalomyelitis in the mouse.
    Iruretagoyena MI, Tobar JA, González PA, Sepúlveda SE, Figueroa CA, Burgos RA, Hancke JL, Kalergis AM.
    J Pharmacol Exp Ther; 2005 Jan 01; 312(1):366-72. PubMed ID: 15331658
    [Abstract] [Full Text] [Related]

  • 11. Differential effects of decoy chemokine (7ND) gene therapy on acute, biphasic and chronic autoimmune encephalomyelitis: implication for pathomechanisms of lesion formation.
    Park IK, Hiraki K, Kohyama K, Matsumoto Y.
    J Neuroimmunol; 2008 Feb 01; 194(1-2):34-43. PubMed ID: 18155779
    [Abstract] [Full Text] [Related]

  • 12. Huperzine A inhibits CCL2 production in experimental autoimmune encephalomyelitis mice and in cultured astrocyte.
    Tian GX, Zhu XQ, Chen Y, Wu GC, Wang J.
    Int J Immunopathol Pharmacol; 2013 Feb 01; 26(3):757-64. PubMed ID: 24067473
    [Abstract] [Full Text] [Related]

  • 13. CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T-cell recruitment to target tissues.
    Villares R, Cadenas V, Lozano M, Almonacid L, Zaballos A, Martínez-A C, Varona R.
    Eur J Immunol; 2009 Jun 01; 39(6):1671-81. PubMed ID: 19499521
    [Abstract] [Full Text] [Related]

  • 14. Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner.
    Rafei M, Campeau PM, Aguilar-Mahecha A, Buchanan M, Williams P, Birman E, Yuan S, Young YK, Boivin MN, Forner K, Basik M, Galipeau J.
    J Immunol; 2009 May 15; 182(10):5994-6002. PubMed ID: 19414750
    [Abstract] [Full Text] [Related]

  • 15. Skin reactivity and local cell recruitment in human atopic and nonatopic subjects by CCL2/MCP-1 and CCL3/MIP-1alpha.
    Gaga M, Ong YE, Benyahia F, Aizen M, Barkans J, Kay AB.
    Allergy; 2008 Jun 15; 63(6):703-11. PubMed ID: 18070228
    [Abstract] [Full Text] [Related]

  • 16. The selective Rho-kinase inhibitor Fasudil is protective and therapeutic in experimental autoimmune encephalomyelitis.
    Sun X, Minohara M, Kikuchi H, Ishizu T, Tanaka M, Piao H, Osoegawa M, Ohyagi Y, Shimokawa H, Kira J.
    J Neuroimmunol; 2006 Nov 15; 180(1-2):126-34. PubMed ID: 16996142
    [Abstract] [Full Text] [Related]

  • 17. 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by inhibiting chemokine synthesis and monocyte trafficking.
    Pedersen LB, Nashold FE, Spach KM, Hayes CE.
    J Neurosci Res; 2007 Aug 15; 85(11):2480-90. PubMed ID: 17600374
    [Abstract] [Full Text] [Related]

  • 18. Neuroprotective effect of the immune system in a mouse model of severe dysmyelinating hereditary neuropathy: enhanced axonal degeneration following disruption of the RAG-1 gene.
    Berghoff M, Samsam M, Müller M, Kobsar I, Toyka KV, Kiefer R, Mäurer M, Martini R.
    Mol Cell Neurosci; 2005 Jan 15; 28(1):118-27. PubMed ID: 15607947
    [Abstract] [Full Text] [Related]

  • 19. Neuroprotection without immunomodulation is not sufficient to reduce first relapse severity in experimental autoimmune encephalomyelitis.
    Hasseldam H, Johansen FF.
    Neuroimmunomodulation; 2010 Jan 15; 17(4):252-64. PubMed ID: 20203531
    [Abstract] [Full Text] [Related]

  • 20. CCL2 and CCL5 mediate leukocyte adhesion in experimental autoimmune encephalomyelitis--an intravital microscopy study.
    dos Santos AC, Barsante MM, Arantes RM, Bernard CC, Teixeira MM, Carvalho-Tavares J.
    J Neuroimmunol; 2005 May 15; 162(1-2):122-9. PubMed ID: 15833367
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.